DelveInsight Report, “Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell products in research and development. The Report covers 20+ companies, which are active in this field with 42 products and many different technologies. This report covers NK cell-based therapies along with drugs that augment (enhance or activate) the NK cells. The Report provides in-depth analysis of the Natural Killer Cell-based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, Technologies and Targeted antigens. The Report provides the NK Cell-based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Reports Highlights: • NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies. • Collaborations & partnering deals • Current Prominent Research Areas and Key Players • Pipeline product profiles NK Cell therapy Technologies and NK cell Augmenting Therapies • Licensing opportunities • Market Drivers and Barriers

1. Natural Killer Cells Therapies- Competitive
Landscape, Technology and Pipeline Analysis
2017

2. 3D STEPS
NKCT
NK Cells are granular lymphocytes that provide innate
immunity. They are the first line of defence against viral
infections and cancer. NK Cells are made up of 5-
15%circulating lymphocytes and are found in peripheral
tissues including liver, peritoneal cavity
NK Cells therapies can act as either Activators (Receptors
such as CD16, NKp44, NKp46 and NKG2D act through
activation) or Inhibitors (Receptors such as Ly-49, KIR and
CD158) of NK Cells
NK Cells are both cytotoxic effectors and regulators of
immune responses and also helps in recognizing
microbial infection and tumour transformation. NK Cells
acts on large number of receptors that deliver either
activating or inhibitory signals on detection of
abnormalities in the target cells
Natural Killer Cells Therapies
DelveInsight © 2017 | All rights reserved

3. Report covers 20+ companies, which are active in this field with 40+products and many
different technologies
Provides comparative analysis at various stages and therapeutics assessment by
monotherapy and combination products and molecule type
Reviews key players involved in the therapeutic development Natural Killer Cells
and special features on late-stage and inactive projects
Report also has market analysis that covers various deals, agreements,
collaborations, acquisitions between various pharma giants and mid-level companies
Key topics covered include strategic competitor assessment, barriers and drivers in the
market along with SWOT analysis
Immune Check Point Activators: Report
DelveInsight © 2017 | All rights reserved

4. Japanese Company;
Kyowa Hakko Kirin
Co. Ltd. is actively
involved in NK cells
augmenting drug
development with
their unique
technology c/d
Potelligent
Technology
Companies are also
conducting preclinical
and clinical studies
for other target
antigens, There are
several technologies
used by different
companies for
making NK cell
products
Kyowa Hakko Kirin Co.,
Ltd. is leading the race
with its NK cells
augmenting product,
“Mogamulizumab” in
Phase III stage
Some Key Findings from the report
DelveInsight © 2017 | All rights reserved
Leading Companies
with NEXT Generation
Technologies are:
NantKwest,
Innate Pharma,
Affimed, &
AltorBioScience
Corporation

5. SWOT ANALYSIS
NK cell Therapy
Pipeline scenario
which includes NK
cell therapies and
NK cell augmenting
therapies
Current Prominent
Research Areas and
Key Players
Licensing
Opportunities
Collaboration &
partnering deals
Pipeline products
profiles NK Cell
therapy
Technologies and NK
cell Augmenting
Therapies
Market
Drivers &
Barriers
Report: Highlights
DelveInsight © 2017 | All rights reserved

6. Complete Information
DelveInsight © 2017 | All rights reserved
For complete information please click below
Or
Write to us at
info@delveinsight.com
CLICK HERE

7. About DelveInsight
Vision
“insight across the value chain”
to help organizations make
important business decisions
through the use and analysis of
actionable market intelligence
Mission
To be the most trusted
marketing research firm & business
consulting firm worldwide.
To be a renowned and premier
data driven solution providers
among Pharma & Biotech
companies.
DelveInsight, market
research and consulting
firm, provides end to end
comprehensive solutions to
the Life Science Industry.
We help our customers in
best decision making
through our expertise in
research & analysis and
comes out with unmatched
data & forecasts
DelveInsight © 2017 | All rights reserved

8. 8
Contact Us:
info@delveinsight.com
+91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight
DelveInsight © 2017 | All rights reserved
Contact Us